Company news
Unicycive Therapeutics, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Unicycive Announces First Quarter Financial Results and Provides Business Update
May 11, 2022
Unicycive Announces Key Opinion Leader Event Highlighting Novel Treatments in Kidney Diseases
April 13, 2022
Unicycive Announces Full Year 2021 Financial Results and Provides Business Update
March 30, 2022
Unicycive To Ring the Nasdaq Closing Bell on March 29, 2022
March 22, 2022
Unicycive Announces Renazorb Pre-clinical and Clinical Data Selected for Presentation at National Kidney Foundation Spring Clinical Meeting
February 1, 2022
Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory Pathway
November 28, 2021
Unicycive Therapeutics Announces Third Quarter 2021 Financial Results
November 10, 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
October 25, 2021
Unicycive Therapeutics Announces Second Quarter 2021 Financial Results
August 15, 2021
Decks
- Investor Presentation (October 2026)
Investor deck · 33 slides · October 2026
- Technical Presentation (June 2024)
Technical · 29 slides · Jun 25, 2024
- Corporate Update (December 2022)
Corporate update · 12 slides · Dec 28, 2022